Inari Medical Net Worth
Inari Medical Net Worth Breakdown | NARI |
Inari Medical Net Worth Analysis
Inari Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Inari Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Inari Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Inari Medical's net worth analysis. One common approach is to calculate Inari Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Inari Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Inari Medical's net worth. This approach calculates the present value of Inari Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Inari Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Inari Medical's net worth. This involves comparing Inari Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Inari Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if Inari Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inari Medical's net worth research are outlined below:
| Inari Medical had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 493.63 M. Net Loss for the year was (1.64 M) with profit before overhead, payroll, taxes, and interest of 338.96 M. | |
| Inari Medical has a frail financial position based on the latest SEC disclosures | |
| Over 96.0% of the company shares are owned by institutional investors | |
| Latest headline from investing.com: Inari medical director William Hoffman sells 3.07m in stock |
Inari Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inari Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inari Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 26th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Inari Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Inari Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inari Medical backward and forwards among themselves. Inari Medical's institutional investor refers to the entity that pools money to purchase Inari Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 1.2 M | Bamco Inc | 2024-09-30 | 1 M | American Century Companies Inc | 2024-09-30 | 979.4 K | Mackenzie Investments | 2024-09-30 | 853.8 K | Point72 Asset Management, L.p. | 2024-09-30 | 805.6 K | Manufacturers Life Insurance Co | 2024-09-30 | 795.1 K | Fuller & Thaler Asset Management Inc | 2024-09-30 | 768.5 K | Bank Of America Corp | 2024-06-30 | 667.2 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 658 K | Blackrock Inc | 2024-06-30 | 8.4 M | Vanguard Group Inc | 2024-09-30 | 5.6 M |
Follow Inari Medical's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.91 B.Market Cap |
|
Project Inari Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | (0.02) | (0.02) |
When accessing Inari Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Inari Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inari Medical's profitability and make more informed investment decisions.
Evaluate Inari Medical's management efficiency
Inari Medical has return on total asset (ROA) of (0.0321) % which means that it has lost $0.0321 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1772) %, meaning that it created substantial loss on money invested by shareholders. Inari Medical's management efficiency ratios could be used to measure how well Inari Medical manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.0056. The current Return On Capital Employed is estimated to decrease to -0.02. As of now, Inari Medical's Non Currrent Assets Other are increasing as compared to previous years. The Inari Medical's current Other Assets is estimated to increase to about 949.3 K, while Other Current Assets are projected to decrease to under 6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.19 | 8.60 | |
| Tangible Book Value Per Share | 1.76 | 2.54 | |
| Enterprise Value Over EBITDA | 517.22 | 491.36 | |
| Price Book Value Ratio | 7.93 | 8.32 | |
| Enterprise Value Multiple | 517.22 | 491.36 | |
| Price Fair Value | 7.93 | 8.32 | |
| Enterprise Value | 3.7 B | 2.4 B |
The strategic initiatives led by Inari Medical's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 4.9234 | Revenue 574.5 M | Quarterly Revenue Growth 0.214 | Revenue Per Share 9.901 | Return On Equity (0.18) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inari Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inari Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inari Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Inari Medical Corporate Filings
F4 | 22nd of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F3 | 18th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 8th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 28th of October 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Inari Medical Earnings per Share Projection vs Actual
Inari Medical Corporate Management
| Angela JD | General Secretary | Profile | |
| Tara Dunn | Senior Development | Profile | |
| John Borrell | Senior Sales | Profile | |
| Kevin Strange | Accounting, Finance | Profile | |
| Janet Byk | VP Accounting | Profile | |
| John CFA | Vice Relations | Profile | |
| Karen Silva | Vice Accounting | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Inari Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Inari Stock please use our How to Invest in Inari Medical guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inari Medical. If investors know Inari will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inari Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.84) | Earnings Share (1.35) | Revenue Per Share 9.901 | Quarterly Revenue Growth 0.214 | Return On Assets (0.03) |
The market value of Inari Medical is measured differently than its book value, which is the value of Inari that is recorded on the company's balance sheet. Investors also form their own opinion of Inari Medical's value that differs from its market value or its book value, called intrinsic value, which is Inari Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inari Medical's market value can be influenced by many factors that don't directly affect Inari Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inari Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inari Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inari Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.